table td { font-size: 16px !important; }
Hit enter to search or ESC to close
About
Overview
Senior Management
Board of Directors
Careers
Science
FASN
Posters/Publications
Investors & Media
Overview
News Releases
Events and Presentations
Corporate Governance
Stock Information
Stock Quote & Chart
Financials & Filings
SEC Filings
Resources
Investor FAQs
Email Alerts
Contact IR
Programs
Overview
Pipeline
Contact
Oncology
Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells
By
Graviton
04/2015
October 27th, 2020
No Comments
About
Overview
Senior Management
Board of Directors
Careers
Science
FASN
Posters/Publications
Investors & Media
Overview
News Releases
Events and Presentations
Corporate Governance
Stock Information
Stock Quote & Chart
Financials & Filings
SEC Filings
Resources
Investor FAQs
Email Alerts
Contact IR
Programs
Overview
Pipeline
Contact